#24-380 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized
BLA for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) accepted for priority review by the U.S. FDA
Reading Time: 2 minutes Stockholm, November 5, 2024: Immedica announces today that the Biologics License Application (BLA) for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) has been successfully validated and accepted for priority review by the U.S. Food and Drug Administration (FDA). Anders
Diamyd Medical and INNODIA partner for Type 1 Diabetes awareness and patient recruitment for the DIAGNODE-3 precision medicine trial
Reading Time: 3 minutes Diamyd Medical has entered a strategic partnership with INNODIA, an international non-profit organization dedicated to advancing research on disease modifying therapies for Type 1 Diabetes. The partnership will leverage INNODIA’s extensive EU-based clinical network with the aim to further amplify patient enrolment
SOFTSWISS Wins SBC Latinoamérica Award for Help Brazil Initiative
Reading Time: 2 minutes SOFTSWISS has won the Socially Responsible Initiative of the Year nomination at the SBC Awards Latinoamérica 2024 for its impactful ‘Help Brazil’ initiative. This recognition underscores the company’s support for Brazilian communities affected by severe flooding earlier this year and its dedication to
Noble Corporation plc Provides Guidance
Reading Time: < 1 minute SUGAR LAND, TEXAS, Nov. 5, 2024 /PRNewswire/ – Noble Corporation plc (“Noble”) (CSE: NOBLE, NYSE: NE) today provides guidance for the quarter ended December 31, 2024. In accordance with Danish legal and stock exchange requirements, Noble announced that for the quarter
Noble Corporation plc Announces Third Quarter 2024 Results and Additional Share Repurchase Authorization
Reading Time: 16 minutes • Closed Diamond acquisition on September 4th • Increased capital return program with additional share repurchase authorization of $400 million • Repurchased 6.9 million of shares in Q3 2024, $0.50 per share dividend declared for Q4 2024, bringing total FY 2024 cash
Buy-back of shares in MTG during week 44, 2024
Reading Time: 2 minutes During the period between 28 October and 1 November 2024 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 94,148 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.
Odfjell SE 3Q24: Odfjell delivered another solid financial result
Reading Time: 2 minutes Odfjell SE today reported its results for the third quarter of 2024. Highlights: Odfjell’s strong performance on safety continues with high operational efficiency and no significant incidents during the quarter. Odfjell delivered another solid financial result in 3Q24, somewhat below record
Nytida acquires Friab’s operations within individual and family care
Reading Time: 2 minutes Nytida, part of the Ambea Group, acquires the care provider Friab’s operations in foster homes, HVB homes (homes for care or residence) and assisted living facilities. The operations included in the acquisition are units within foster home care, four HVB homes
Nivika issues new senior unsecured green bonds of SEK 400 million
Reading Time: 2 minutes NOT FOR DISTRIBUTION IN OR TO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL